Roles of omental and bone marrow adipocytes in tumor biology

References

• Choi J, Cha YJ, Koo JS. Adipocyte biology in breast cancer: From silent bystander to active facilitator. Prog Lipid Res. 2018;69:11–20.
   PubMed Web of Science ®Google Scholar
• Hoy AJ, Balaban S, Saunders DN. Adipocyte-tumor cell metabolic crosstalk in breast cancer. Trends Mol Med. 2017;23:381–392.
   PubMed Web of Science ®Google Scholar
• Wilkosz S, Ireland G, Khwaja N, et al. A comparative study of the structure of human and murine greater omentum. Anat Embryol (Berl). 2005;209:251–261.
   PubMedGoogle Scholar
• Hall JC, Heel KA, Papadimitriou JM, et al. The pathobiology of peritonitis. Gastroenterology. 1998;114:185–196.
   PubMed Web of Science ®Google Scholar
• Goldsmith HS. Role of the omentum in the treatment of Alzheimer’s disease. Neurol Res. 2001;23:555–564.
   PubMed Web of Science ®Google Scholar
• Meza-Perez S, Randall TD. Immunological functions of the omentum. Trends Immunol. 2017;38:526–536.
   PubMed Web of Science ®Google Scholar
• Beelen RH, Fluitsma DM, Hoefsmit EC. The cellular composition of omentum milky spots and the ultrastructure of milky spot macrophages and reticulum cells. J Reticuloendothel Soc. 1980;28:585–599.
   PubMedGoogle Scholar
• Cranshaw ML, Leak LV. Milky spots of the omentum: a source of peritoneal cells in the normal and stimulated animal. Arch Histol Cytol. 1990;53(Suppl):165–177.
   PubMedGoogle Scholar
• Gerber SA, Rybalko VY, Bigelow CE, et al. Preferential attachment of peritoneal tumor metastases to omental immune aggregates and possible role of a unique vascular microenvironment in metastatic survival and growth. Am J Pathol. 2006;169:1739–1752.
   PubMed Web of Science ®Google Scholar
• Liu J, Geng X, Li Y. Milky spots: omental functional units and hotbeds for peritoneal cancer metastasis. Tumour Biol. 2016;37:5715–5726.
   PubMedGoogle Scholar
• Aroeira LS, Aguilera A, Sanchez-Tomero JA, et al. Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: pathologic significance and potential therapeutic interventions. J Am Soc Nephrol. 2007;18:2004–2013.
   PubMed Web of Science ®Google Scholar
• Arner P. Insulin resistance in type 2 diabetes: role of fatty acids. Diabetes Metab Res Rev. 2002;18(Suppl 2):S5–9.
   PubMedGoogle Scholar
• Michaud A, Lacroix-Pepin N, Pelletier M, et al. Expression of genes related to prostaglandin synthesis or signaling in human subcutaneous and omental adipose tissue: depot differences and modulation by adipogenesis. Mediators Inflamm. 2014;2014:451620.
   PubMedGoogle Scholar
• Gesta S, Bluher M, Yamamoto Y, et al. Evidence for a role of developmental genes in the origin of obesity and body fat distribution. Proc Natl Acad Sci U S A. 2006;103:6676–6681.
   PubMed Web of Science ®Google Scholar
• MacLaren R, Cui W, Simard S, et al. Influence of obesity and insulin sensitivity on insulin signaling genes in human omental and subcutaneous adipose tissue. J Lipid Res. 2008;49:308–323.
   PubMed Web of Science ®Google Scholar
• Perrini S, Laviola L, Cignarelli A, et al. Fat depot-related differences in gene expression, adiponectin secretion, and insulin action and signalling in human adipocytes differentiated in vitro from precursor stromal cells. Diabetologia. 2008;51:155–164.
   PubMed Web of Science ®Google Scholar
• Perez-Perez R, Ortega-Delgado FJ, Garcia-Santos E, et al. Differential proteomics of omental and subcutaneous adipose tissue reflects their unalike biochemical and metabolic properties. J Proteome Res. 2009;8:1682–1693.
   PubMed Web of Science ®Google Scholar
• Jove M, Moreno-Navarrete JM, Pamplona R, et al. Human omental and subcutaneous adipose tissue exhibit specific lipidomic signatures. Faseb J. 2014;28:1071–1081.
   PubMed Web of Science ®Google Scholar
• Chau YY, Bandiera R, Serrels A, et al. Visceral and subcutaneous fat have different origins and evidence supports a mesothelial source. Nat Cell Biol. 2014;16:367–375.
   PubMed Web of Science ®Google Scholar
• Kranendonk ME, van Herwaarden JA, Stupkova T, et al. Inflammatory characteristics of distinct abdominal adipose tissue depots relate differently to metabolic risk factors for cardiovascular disease: distinct fat depots and vascular risk factors. Atherosclerosis. 2015;239:419–427.
   PubMed Web of Science ®Google Scholar
• Tchkonia T, Tchoukalova YD, Giorgadze N, et al. Abundance of two human preadipocyte subtypes with distinct capacities for replication, adipogenesis, and apoptosis varies among fat depots. Am J Physiol Endocrinol Metab. 2005;288:E267–277.
   PubMed Web of Science ®Google Scholar
• Chew SH, Okazaki Y, Nagai H, et al. Cancer-promoting role of adipocytes in asbestos-induced mesothelial carcinogenesis through dysregulated adipocytokine production. Carcinogenesis. 2014;35:164–172.
   PubMed Web of Science ®Google Scholar
• Koppe MJ, Nagtegaal ID, de Wilt JH, et al. Recent insights into the pathophysiology of omental metastases. J Surg Oncol. 2014;110:670–675.
   PubMed Web of Science ®Google Scholar
• Doig T, Monaghan H. Sampling the omentum in ovarian neoplasia: when one block is enough. Int J Gynecol Cancer. 2006;16:36–40.
   PubMed Web of Science ®Google Scholar
• Lehr S, Hartwig S, Sell H. Adipokines: a treasure trove for the discovery of biomarkers for metabolic disorders. Proteomics Clin Appl. 2012;6:91–101.
   PubMed Web of Science ®Google Scholar
• Bluher M, Mantzoros CS. From leptin to other adipokines in health and disease: facts and expectations at the beginning of the 21st century. Metabolism. 2015;64:131–145.
   PubMed Web of Science ®Google Scholar
• Bluher M. Adipokines - removing road blocks to obesity and diabetes therapy. Mol Metab. 2014;3:230–240.
   PubMed Web of Science ®Google Scholar
• Bluher M. Clinical relevance of adipokines. Diabetes Metab J. 2012;36:317–327.
   PubMedGoogle Scholar
• Jarde T, Caldefie-Chezet F, Damez M, et al. Leptin and leptin receptor involvement in cancer development: a study on human primary breast carcinoma. Oncol Rep. 2008;19:905–911.
   PubMed Web of Science ®Google Scholar
• Nieman KM, Kenny HA, Penicka CV, et al. Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat Med. 2011;17:1498–1503.
   PubMed Web of Science ®Google Scholar
• Hu J, Liu Z, Wang X. Does TP53 mutation promote ovarian cancer metastasis to omentum by regulating lipid metabolism? Med Hypotheses. 2013;81:515–520.
   PubMed Web of Science ®Google Scholar
• Fan Y, Gan Y, Shen Y, et al. Leptin signaling enhances cell invasion and promotes the metastasis of human pancreatic cancer via increasing MMP-13 production. Oncotarget. 2015;6:16120–16134.
   PubMedGoogle Scholar
• Feygenzon V, Loewenstein S, Lubezky N, et al. Unique cellular interactions between pancreatic cancer cells and the omentum. PLoS One. 2017;12:e0179862.
   PubMed Web of Science ®Google Scholar
• Ladanyi A, Mukherjee A, Kenny HA, et al. Adipocyte-induced CD36 expression drives ovarian cancer progression and metastasis. Oncogene. 2018;37:2285–2301.
   PubMed Web of Science ®Google Scholar
• Clark R, Krishnan V, Schoof M, et al. Milky spots promote ovarian cancer metastatic colonization of peritoneal adipose in experimental models. Am J Pathol. 2013;183:576–591.
   PubMed Web of Science ®Google Scholar
• Xiang F, Wu K, Liu Y, et al. Omental adipocytes enhance the invasiveness of gastric cancer cells by oleic acid-induced activation of the PI3K-Akt signaling pathway. Int J Biochem Cell Biol. 2017;84:14–21.
   PubMed Web of Science ®Google Scholar
• Vaughan M. The production and release of glycerol by adipose tissue incubated in vitro. J Biol Chem. 1962;237:3354–3358.
   PubMed Web of Science ®Google Scholar
• Maeda N, Funahashi T, Shimomura I. Metabolic impact of adipose and hepatic glycerol channels aquaporin 7 and aquaporin 9. Nat Clin Pract Endocrinol Metab. 2008;4:627–634.
   PubMedGoogle Scholar
• Mandache E, Moldoveanu E, Savi G. The involvement of omentum and its milky spots in the dynamics of peritoneal macrophages. Morphol Embryol (Bucur). 1985;31:137–142.
   PubMedGoogle Scholar
• Rangel-Moreno J, Moyron-Quiroz JE, Carragher DM, et al. Omental milky spots develop in the absence of lymphoid tissue-inducer cells and support B and T cell responses to peritoneal antigens. Immunity. 2009;30:731–743.
   PubMed Web of Science ®Google Scholar
• Takemori N, Hirai K, Onodera R, et al. Light and electron microscope study of splenoportal milky spots in New Zealand black mice: comparison between splenoportal milky spots and aberrant spleens. J Anat. 1995;186(Pt 2):287–299.
   PubMedGoogle Scholar
• Muller R. PPARbeta/delta in human cancer. Biochimie. 2017;136:90–99.
   PubMed Web of Science ®Google Scholar
• Schumann T, Adhikary T, Wortmann A, et al. Deregulation of PPARbeta/delta target genes in tumor-associated macrophages by fatty acid ligands in the ovarian cancer microenvironment. Oncotarget. 2015;6:13416–13433.
   PubMed Web of Science ®Google Scholar
• Xu HE, Lambert MH, Montana VG, et al. Molecular recognition of fatty acids by peroxisome proliferator-activated receptors. Mol Cell. 1999;3:397–403.
   PubMed Web of Science ®Google Scholar
• Vosper H, Patel L, Graham TL, et al. The peroxisome proliferator-activated receptor delta promotes lipid accumulation in human macrophages. J Biol Chem. 2001;276:44258–44265.
   PubMed Web of Science ®Google Scholar
• Gueraud F, Tache S, Steghens JP, et al. Dietary polyunsaturated fatty acids and heme iron induce oxidative stress biomarkers and a cancer promoting environment in the colon of rats. Free Radic Biol Med. 2015;83:192–200.
   PubMed Web of Science ®Google Scholar
• Khadge S, Sharp JG, McGuire TR, et al. Lipid inflammatory mediators in cancer progression and therapy. Adv Exp Med Biol. 2017;1036:145–156.
   PubMedGoogle Scholar
• Sorensen EW, Gerber SA, Sedlacek AL, et al. Omental immune aggregates and tumor metastasis within the peritoneal cavity. Immunol Res. 2009;45:185–194.
   PubMed Web of Science ®Google Scholar
• Zhang QX, Magovern CJ, Mack CA, et al. Vascular endothelial growth factor is the major angiogenic factor in omentum: mechanism of the omentum-mediated angiogenesis. J Surg Res. 1997;67:147–154.
   PubMed Web of Science ®Google Scholar
• Choi HJ, Armaiz Pena GN, Pradeep S, et al. Anti-vascular therapies in ovarian cancer: moving beyond anti-VEGF approaches. Cancer Metastasis Rev. 2015;34:19–40.
   PubMed Web of Science ®Google Scholar
• Krock BL, Skuli N, Simon MC. Hypoxia-induced angiogenesis: good and evil. Genes Cancer. 2011;2:1117–1133.
   PubMedGoogle Scholar
• Chkourko Gusky H, Diedrich J, MacDougald OA, et al. Omentum and bone marrow: how adipocyte-rich organs create tumour microenvironments conducive for metastatic progression. Obes Rev. 2016;17:1015–1029.
   PubMed Web of Science ®Google Scholar
• Berry R, Rodeheffer MS, Rosen CJ, et al. Adipose tissue residing progenitors (adipocyte lineage progenitors and adipose derived stem cells (ADSC). Curr Mol Biol Rep. 2015;1:101–109.
   PubMedGoogle Scholar
• Georgiou KR, Hui SK, Xian CJ. Regulatory pathways associated with bone loss and bone marrow adiposity caused by aging, chemotherapy, glucocorticoid therapy and radiotherapy. Am J Stem Cells. 2012;1:205–224.
   PubMedGoogle Scholar
• Cawthorn WP, Scheller EL, Learman BS, et al. Bone marrow adipose tissue is an endocrine organ that contributes to increased circulating adiponectin during caloric restriction. Cell Metab. 2014;20:368–375.
   PubMed Web of Science ®Google Scholar
• Berendsen AD, Olsen BR. Osteoblast-adipocyte lineage plasticity in tissue development, maintenance and pathology. Cell Mol Life Sci. 2014;71:493–497.
   PubMed Web of Science ®Google Scholar
• Fazeli PK, Horowitz MC, MacDougald OA, et al. Marrow fat and bone–new perspectives. J Clin Endocrinol Metab. 2013;98:935–945.
   PubMed Web of Science ®Google Scholar
• Scheller EL, Doucette CR, Learman BS, et al. Region-specific variation in the properties of skeletal adipocytes reveals regulated and constitutive marrow adipose tissues. Nat Commun. 2015;6:7808.
   PubMed Web of Science ®Google Scholar
• Roche B, David V, Vanden-Bossche A, et al. Structure and quantification of microvascularisation within mouse long bones: what and how should we measure? Bone. 2012;50:390–399.
   PubMed Web of Science ®Google Scholar
• Langin D. Control of fatty acid and glycerol release in adipose tissue lipolysis. C R Biol. 2006;329:598–607. discussion 653–595.
   PubMed Web of Science ®Google Scholar
• Lecka-Czernik B. Marrow fat metabolism is linked to the systemic energy metabolism. Bone. 2012;50:534–539.
   PubMed Web of Science ®Google Scholar
• Nishio M, Yoneshiro T, Nakahara M, et al. Production of functional classical brown adipocytes from human pluripotent stem cells using specific hemopoietin cocktail without gene transfer. Cell Metab. 2012;16:394–406.
   PubMed Web of Science ®Google Scholar
• Lecka-Czernik B, Gubrij I, Moerman EJ, et al. Inhibition of Osf2/Cbfa1 expression and terminal osteoblast differentiation by PPARgamma2. J Cell Biochem. 1999;74:357–371.
   PubMed Web of Science ®Google Scholar
• Shockley KR, Lazarenko OP, Czernik PJ, et al. PPARgamma2 nuclear receptor controls multiple regulatory pathways of osteoblast differentiation from marrow mesenchymal stem cells. J Cell Biochem. 2009;106:232–246.
   PubMed Web of Science ®Google Scholar
• Hardouin P, Rharass T, Lucas S. Bone marrow adipose tissue: to be or not to be a typical adipose tissue? Front Endocrinol (Lausanne). 2016;7:85.
   PubMed Web of Science ®Google Scholar
• Roodman GD. Genes associate with abnormal bone cell activity in bone metastasis. Cancer Metastasis Rev. 2012;31:569–578.
   PubMed Web of Science ®Google Scholar
• Paula FJ, Rosen CJ. Obesity, diabetes mellitus and last but not least, osteoporosis. Arq Bras Endocrinol Metabol. 2010;54:150–157.
   PubMedGoogle Scholar
• Liu LF, Shen WJ, Ueno M, et al. Characterization of age-related gene expression profiling in bone marrow and epididymal adipocytes. BMC Genomics. 2011;12:212.
   PubMed Web of Science ®Google Scholar
• Poloni A, Maurizi G, Serrani F, et al. Molecular and functional characterization of human bone marrow adipocytes. Exp Hematol. 2013;41:558–566.e552.
   PubMed Web of Science ®Google Scholar
• Gasparrini M, Rivas D, Elbaz A, et al. Differential expression of cytokines in subcutaneous and marrow fat of aging C57BL/6J mice. Exp Gerontol. 2009;44:613–618.
   PubMed Web of Science ®Google Scholar
• Coleman RE. Metastatic bone disease: clinical features, pathophysiology and treatment strategies. Cancer Treat Rev. 2001;27:165–176.
   PubMed Web of Science ®Google Scholar
• Roodman GD. Mechanisms of bone metastasis. N Engl J Med. 2004;350:1655–1664.
   PubMed Web of Science ®Google Scholar
• Langley RR, Fidler IJ. The seed and soil hypothesis revisited–the role of tumor-stroma interactions in metastasis to different organs. Int J Cancer. 2011;128:2527–2535.
   PubMed Web of Science ®Google Scholar
• Kurahashi N, Iwasaki M, Sasazuki S, et al. Association of body mass index and height with risk of prostate cancer among middle-aged Japanese men. Br J Cancer. 2006;94:740–742.
   PubMed Web of Science ®Google Scholar
• Scosyrev E, Messing EM, Mohile S, et al. Prostate cancer in the elderly: frequency of advanced disease at presentation and disease-specific mortality. Cancer. 2012;118:3062–3070.
   PubMedGoogle Scholar
• Scosyrev E, Wu G, Mohile S, et al. Prostate-specific antigen screening for prostate cancer and the risk of overt metastatic disease at presentation: analysis of trends over time. Cancer. 2012;118:5768–5776.
   PubMed Web of Science ®Google Scholar
• Imbriaco M, Larson SM, Yeung HW, et al. A new parameter for measuring metastatic bone involvement by prostate cancer: the Bone Scan Index. Clin Cancer Res. 1998;4:1765–1772.
   PubMed Web of Science ®Google Scholar
• Brown MD, Hart CA, Gazi E, et al. Promotion of prostatic metastatic migration towards human bone marrow stoma by omega 6 and its inhibition by omega 3 PUFAs. Br J Cancer. 2006;94:842–853.
   PubMed Web of Science ®Google Scholar
• Gazi E, Gardner P, Lockyer NP, et al. Direct evidence of lipid translocation between adipocytes and prostate cancer cells with imaging FTIR microspectroscopy. J Lipid Res. 2007;48:1846–1856.
   PubMed Web of Science ®Google Scholar
• Caers J, Deleu S, Belaid Z, et al. Neighboring adipocytes participate in the bone marrow microenvironment of multiple myeloma cells. Leukemia. 2007;21:1580–1584.
   PubMed Web of Science ®Google Scholar
• Bussard KM, Gay CV, Mastro AM. The bone microenvironment in metastasis; what is special about bone? Cancer Metastasis Rev. 2008;27:41–55.
   PubMed Web of Science ®Google Scholar
• Thobe MN, Clark RJ, Bainer RO, et al. From prostate to bone: key players in prostate cancer bone metastasis. Cancers (Basel). 2011;3:478–493.
   PubMedGoogle Scholar
• Templeton ZS, Lie WR, Wang W, et al. Breast cancer cell colonization of the human bone marrow adipose tissue niche. Neoplasia. 2015;17:849–861.
   PubMed Web of Science ®Google Scholar
• Yue R, Zhou BO, Shimada IS, et al. Leptin receptor promotes adipogenesis and reduces osteogenesis by regulating mesenchymal stromal cells in adult bone marrow. Cell Stem Cell. 2016;18:782–796.
   PubMed Web of Science ®Google Scholar
• Zhou BO, Yu H, Yue R, et al. Bone marrow adipocytes promote the regeneration of stem cells and haematopoiesis by secreting SCF. Nat Cell Biol. 2017;19:891–903.
   PubMed Web of Science ®Google Scholar
• Snoussi K, Strosberg AD, Bouaouina N, et al. Leptin and leptin receptor polymorphisms are associated with increased risk and poor prognosis of breast carcinoma. BMC Cancer. 2006;6:38.
   PubMed Web of Science ®Google Scholar
• Jarde T, Perrier S, Vasson MP, et al. Molecular mechanisms of leptin and adiponectin in breast cancer. Eur J Cancer. 2011;47:33–43.
   PubMed Web of Science ®Google Scholar
• Kumar J, Fang H, McCulloch DR, et al. Leptin receptor signaling via janus kinase 2/signal transducer and activator of transcription 3 impacts on ovarian cancer cell phenotypes. Oncotarget. 2017;8:93530–93540.
   PubMedGoogle Scholar
• Dalamaga M, Diakopoulos KN, Mantzoros CS. The role of adiponectin in cancer: a review of current evidence. Endocr Rev. 2012;33:547–594.
   PubMed Web of Science ®Google Scholar
• Libby EF, Frost AR, Demark-Wahnefried W, et al. Linking adiponectin and autophagy in the regulation of breast cancer metastasis. J Mol Med (Berl). 2014;92:1015–1023.
   PubMed Web of Science ®Google Scholar
• Jia Z, Liu Y, Cui S. Adiponectin induces breast cancer cell migration and growth factor expression. Cell Biochem Biophys. 2014;70:1239–1245.
   PubMed Web of Science ®Google Scholar
• Laharrague P, Fontanilles AM, Tkaczuk J, et al. Inflammatory/haematopoietic cytokine production by human bone marrow adipocytes. Eur Cytokine Netw. 2000;11:634–639.
   PubMed Web of Science ®Google Scholar
• Wang L, Cao L, Wang H, et al. Cancer-associated fibroblasts enhance metastatic potential of lung cancer cells through IL-6/STAT3 signaling pathway. Oncotarget. 2017;8:76116–76128.
   PubMedGoogle Scholar
• Tu Y, Gardner A, Lichtenstein A. The phosphatidylinositol 3-kinase/AKT kinase pathway in multiple myeloma plasma cells: roles in cytokine-dependent survival and proliferative responses. Cancer Res. 2000;60:6763–6770.
   PubMed Web of Science ®Google Scholar
• Knupfer H, Preiss R. sIL-6R: more than an agonist? Immunol Cell Biol. 2008;86:87–91.
   PubMed Web of Science ®Google Scholar
• Hardaway AL, Herroon MK, Rajagurubandara E, et al. Marrow adipocyte-derived CXCL1 and CXCL2 contribute to osteolysis in metastatic prostate cancer. Clin Exp Metastasis. 2015;32:353–368.
   PubMed Web of Science ®Google Scholar
• Chen GL, Luo Y, Eriksson D, et al. High fat diet increases melanoma cell growth in the bone marrow by inducing osteopontin and interleukin 6. Oncotarget. 2016;7:26653–26669.
   PubMedGoogle Scholar
• De Filippo K, Dudeck A, Hasenberg M, et al. Mast cell and macrophage chemokines CXCL1/CXCL2 control the early stage of neutrophil recruitment during tissue inflammation. Blood. 2013;121:4930–4937.
   PubMed Web of Science ®Google Scholar
• Acharyya S, Oskarsson T, Vanharanta S, et al. A CXCL1 paracrine network links cancer chemoresistance and metastasis. Cell. 2012;150:165–178.
   PubMed Web of Science ®Google Scholar
• Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol. 2009;9:162–174.
   PubMed Web of Science ®Google Scholar
• Kalinski P. Regulation of immune responses by prostaglandin E2. J Immunol. 2012;188:21–28.
   PubMed Web of Science ®Google Scholar
• Safina A, Sotomayor P, Limoge M, et al. TAK1-TAB2 signaling contributes to bone destruction by breast carcinoma cells. Mol Cancer Res. 2011;9:1042–1053.
   PubMed Web of Science ®Google Scholar
• Singh B, Berry JA, Shoher A, et al. COX-2 involvement in breast cancer metastasis to bone. Oncogene. 2007;26:3789–3796.
   PubMed Web of Science ®Google Scholar
• Li Z, Schem C, Shi YH, et al. Increased COX2 expression enhances tumor-induced osteoclastic lesions in breast cancer bone metastasis. Clin Exp Metastasis. 2008;25:389–400.
   PubMed Web of Science ®Google Scholar
• Herroon MK, Rajagurubandara E, Hardaway AL, et al. Bone marrow adipocytes promote tumor growth in bone via FABP4-dependent mechanisms. Oncotarget. 2013;4:2108–2123.
   PubMedGoogle Scholar
• Arendt LM, McCready J, Keller PJ, et al. Obesity promotes breast cancer by CCL2-mediated macrophage recruitment and angiogenesis. Cancer Res. 2013;73:6080–6093.
   PubMed Web of Science ®Google Scholar
• Wang J, Chen GL, Cao S, et al. Adipogenic niches for melanoma cell colonization and growth in bone marrow. Lab Invest. 2017;97:737–745.
   PubMed Web of Science ®Google Scholar
• Diedrich JD, Rajagurubandara E, Herroon MK, et al. Bone marrow adipocytes promote the Warburg phenotype in metastatic prostate tumors via HIF-1alpha activation. Oncotarget. 2016;7:64854–64877.
   PubMedGoogle Scholar
• Sumida T. Clinical and experimental study on fatty acid composition of bone marrow lipid in hematologic disorders. Acta Med Nagasaki. 1965;9:222–241.
   PubMedGoogle Scholar
• Hughes-Fulford M, Li CF, Boonyaratanakornkit J, et al. Arachidonic acid activates phosphatidylinositol 3-kinase signaling and induces gene expression in prostate cancer. Cancer Res. 2006;66:1427–1433.
   PubMed Web of Science ®Google Scholar
• Rose DP. Effects of dietary fatty acids on breast and prostate cancers: evidence from in vitro experiments and animal studies. Am J Clin Nutr. 1997;66:1513s–1522s.
   PubMed Web of Science ®Google Scholar
• Tjandrawinata RR, Dahiya R, Hughes-Fulford M. Induction of cyclo-oxygenase-2 mRNA by prostaglandin E2 in human prostatic carcinoma cells. Br J Cancer. 1997;75:1111–1118.
   PubMed Web of Science ®Google Scholar
• Kelesidis I, Kelesidis T, Mantzoros CS. Adiponectin and cancer: a systematic review. Br J Cancer. 2006;94:1221–1225.
   PubMed Web of Science ®Google Scholar
• Behan JW, Yun JP, Proektor MP, et al. Adipocytes impair leukemia treatment in mice. Cancer Res. 2009;69:7867–7874.
   PubMed Web of Science ®Google Scholar
• Trotter TN, Gibson JT, Sherpa TL, et al. Adipocyte-lineage cells support growth and dissemination of multiple myeloma in bone. Am J Pathol. 2016;186:3054–3063.
   PubMed Web of Science ®Google Scholar
• Chen Q, Yuan Y, Chen T. Morphology, differentiation and adhesion molecule expression changes of bone marrow mesenchymal stem cells from acute myeloid leukemia patients. Mol Med Rep. 2014;9:293–298.
   PubMed Web of Science ®Google Scholar
• Naveiras O, Nardi V, Wenzel PL, et al. Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment. Nature. 2009;460:259–263.
   PubMed Web of Science ®Google Scholar
• Lu W, Wan Y, Li Z, et al. Growth differentiation factor 15 contributes to marrow adipocyte remodeling in response to the growth of leukemic cells. J Exp Clin Cancer Res. 2018;37:66.
   PubMed Web of Science ®Google Scholar
• Zaidi N, Lupien L, Kuemmerle NB, et al. Lipogenesis and lipolysis: the pathways exploited by the cancer cells to acquire fatty acids. Prog Lipid Res. 2013;52:585–589.
   PubMed Web of Science ®Google Scholar
• Harte AL, Tripathi G, Piya MK, et al. NFkappaB as a potent regulator of inflammation in human adipose tissue, influenced by depot, adiposity, T2DM status, and TNFalpha. Obesity (Silver Spring). 2013;21:2322–2330.
   PubMed Web of Science ®Google Scholar
• Yu W, Cao DD, Li QB, et al. Adipocytes secreted leptin is a pro-tumor factor for survival of multiple myeloma under chemotherapy. Oncotarget. 2016;7:86075–86086.
   PubMedGoogle Scholar
• Liu Z, Xu J, He J, et al. Mature adipocytes in bone marrow protect myeloma cells against chemotherapy through autophagy activation. Oncotarget. 2015;6:34329–34341.
   PubMedGoogle Scholar
• Fowler JA, Lwin ST, Drake MT, et al. Host-derived adiponectin is tumor-suppressive and a novel therapeutic target for multiple myeloma and the associated bone disease. Blood. 2011;118:5872–5882.
   PubMed Web of Science ®Google Scholar
• Medina EA, Oberheu K, Polusani SR, et al. PKA/AMPK signaling in relation to adiponectin’s antiproliferative effect on multiple myeloma cells. Leukemia. 2014;28:2080–2089.
   PubMed Web of Science ®Google Scholar
• Venkateshaiah SU, Khan S, Ling W, et al. NAMPT/PBEF1 enzymatic activity is indispensable for myeloma cell growth and osteoclast activity. Exp Hematol. 2013;41:547–557.e542.
   PubMed Web of Science ®Google Scholar
• Gado K, Domjan G, Hegyesi H, et al. Role of INTERLEUKIN-6 in the pathogenesis of multiple myeloma. Cell Biol Int. 2000;24:195–209.
   PubMed Web of Science ®Google Scholar
• Birmann BM, Neuhouser ML, Rosner B, et al. Prediagnosis biomarkers of insulin-like growth factor-1, insulin, and interleukin-6 dysregulation and multiple myeloma risk in the multiple myeloma cohort consortium. Blood. 2012;120:4929–4937.
   PubMed Web of Science ®Google Scholar
• Jourdan M, Tarte K, Legouffe E, et al. Tumor necrosis factor is a survival and proliferation factor for human myeloma cells. Eur Cytokine Netw. 1999;10:65–70.
   PubMed Web of Science ®Google Scholar
• Arendt BK, Velazquez-Dones A, Tschumper RC, et al. Interleukin 6 induces monocyte chemoattractant protein-1 expression in myeloma cells. Leukemia. 2002;16:2142–2147.
   PubMed Web of Science ®Google Scholar
• Zheng Y, Yang J, Qian J, et al. PSGL-1/selectin and ICAM-1/CD18 interactions are involved in macrophage-induced drug resistance in myeloma. Leukemia. 2013;27:702–710.
   PubMed Web of Science ®Google Scholar
• Uddin S, Mohammad RM. Role of leptin and leptin receptors in hematological malignancies. Leuk Lymphoma. 2016;57:10–16.
   PubMed Web of Science ®Google Scholar
• Kohler JA, Moon RJ, Wright S, et al. Increased adiposity and altered adipocyte function in female survivors of childhood acute lymphoblastic leukaemia treated without cranial radiation. Horm Res Paediatr. 2011;75:433–440.
   PubMed Web of Science ®Google Scholar
• Foss B, Mentzoni L, Bruserud O. Effects of vascular endothelial growth factor on acute myelogenous leukemia blasts. J Hematother Stem Cell Res. 2001;10:81–93.
   PubMedGoogle Scholar
• Gorska E, Popko K, Wasik M. Leptin receptor in childhood acute leukemias. Adv Exp Med Biol. 2013;756:155–161.
   PubMed Web of Science ®Google Scholar
• Tabe Y, Konopleva M, Munsell MF, et al. PML-RARalpha is associated with leptin-receptor induction: the role of mesenchymal stem cell-derived adipocytes in APL cell survival. Blood. 2004;103:1815–1822.
   PubMed Web of Science ®Google Scholar
• Juarez J, Bradstock KF, Gottlieb DJ, et al. Effects of inhibitors of the chemokine receptor CXCR4 on acute lymphoblastic leukemia cells in vitro. Leukemia. 2003;17:1294–1300.
   PubMed Web of Science ®Google Scholar
• Pramanik R, Sheng X, Ichihara B, et al. Adipose tissue attracts and protects acute lymphoblastic leukemia cells from chemotherapy. Leuk Res. 2013;37:503–509.
   PubMed Web of Science ®Google Scholar
• Shafat MS, Oellerich T, Mohr S, et al. Leukemic blasts program bone marrow adipocytes to generate a protumoral microenvironment. Blood. 2017;129:1320–1332.
   PubMed Web of Science ®Google Scholar
• Tabe Y, Yamamoto S, Saitoh K, et al. Bone marrow adipocytes facilitate fatty acid oxidation activating AMPK and a transcriptional network supporting survival of acute monocytic leukemia cells. Cancer Res. 2017;77:1453–1464.
   PubMed Web of Science ®Google Scholar
• Lu W, Weng W, Zhu Q, et al. Small bone marrow adipocytes predict poor prognosis in acute myeloid leukemia. Haematologica. 2018;103:e21–e24.
   PubMed Web of Science ®Google Scholar
• Veldhuis-Vlug AG, Rosen CJ. Clinical implications of bone marrow adiposity. J Intern Med. 2018;283:121–139.
   PubMed Web of Science ®Google Scholar
• Sheng X, Mittelman SD. The role of adipose tissue and obesity in causing treatment resistance of acute lymphoblastic leukemia. Front Pediatr. 2014;2:53.
   PubMed Web of Science ®Google Scholar
• Holley RW, Baldwin JH, Kiernan JA. Control of growth of a tumor cell by linoleic acid. Proc Natl Acad Sci U S A. 1974;71:3976–3978.
   PubMed Web of Science ®Google Scholar
• Butler M, Huzel N, Barnabe N. Unsaturated fatty acids enhance cell yields and perturb the energy metabolism of an antibody-secreting hybridoma. Biochem J. 1997;322(Pt 2):615–623.
   PubMedGoogle Scholar
• Sravan Kumar G, Das UN. Cytotoxic action of alpha-linolenic and eicosapentaenoic acids on myeloma cells in vitro. Prostaglandins Leukot Essent Fatty Acids. 1997;56:285–293.
   PubMed Web of Science ®Google Scholar
• Finstad HS, Myhrstad MC, Heimli H, et al. Multiplication and death-type of leukemia cell lines exposed to very long-chain polyunsaturated fatty acids. Leukemia. 1998;12:921–929.
   PubMed Web of Science ®Google Scholar
• Sarraf P, Frederich RC, Turner EM, et al. Multiple cytokines and acute inflammation raise mouse leptin levels: potential role in inflammatory anorexia. J Exp Med. 1997;185:171–175.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Perez RR, Xu Y, Guo S, et al. Leptin upregulates VEGF in breast cancer via canonic and non-canonical signalling pathways and NFkappaB/HIF-1alpha activation. Cell Signal. 2010;22:1350–1362.
   PubMed Web of Science ®Google Scholar
• Shpilman M, Niv-Spector L, Katz M, et al. Development and characterization of high affinity leptins and leptin antagonists. J Biol Chem. 2011;286:4429–4442.
   PubMed Web of Science ®Google Scholar
• Rene Gonzalez R, Watters A, Xu Y, et al. Leptin-signaling inhibition results in efficient anti-tumor activity in estrogen receptor positive or negative breast cancer. Breast Cancer Res. 2009;11:R36.
   PubMed Web of Science ®Google Scholar
• Harmon T, Harbuzariu A, Lanier V, et al. Nanoparticle-linked antagonist for leptin signaling inhibition in breast cancer. World J Clin Oncol. 2017;8:54–66.
   PubMed Web of Science ®Google Scholar
• Otvos L Jr., Kovalszky I, Riolfi M, et al. Efficacy of a leptin receptor antagonist peptide in a mouse model of triple-negative breast cancer. Eur J Cancer. 2011;47:1578–1584.
   PubMed Web of Science ®Google Scholar
• Beccari S, Kovalszky I, Wade JD, et al. Designer peptide antagonist of the leptin receptor with peripheral antineoplastic activity. Peptides. 2013;44:127–134.
   PubMed Web of Science ®Google Scholar
• Catalano S, Leggio A, Barone I, et al. A novel leptin antagonist peptide inhibits breast cancer growth in vitro and in vivo. J Cell Mol Med. 2015;19:1122–1132.
   PubMed Web of Science ®Google Scholar
• Gillespie C, Guo S, Zhou W, et al. Abstract 825: leptin signaling disruption prevents DMBA-induced mammary tumors in lean and diet-induced-obesity (DIO) mice. Cancer Res. 2011;71:825.
   Web of Science ®Google Scholar
• Azab AK, Runnels JM, Pitsillides C, et al. CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy. Blood. 2009;113:4341–4351.
   PubMed Web of Science ®Google Scholar
• Hoellenriegel J, Zboralski D, Maasch C, et al. The Spiegelmer NOX-A12, a novel CXCL12 inhibitor, interferes with chronic lymphocytic leukemia cell motility and causes chemosensitization. Blood. 2014;123:1032–1039.
   PubMed Web of Science ®Google Scholar
• Obmolova G, Teplyakov A, Malia TJ, et al. Structural basis for high selectivity of anti-CCL2 neutralizing antibody CNTO 888. Mol Immunol. 2012;51:227–233.
   PubMed Web of Science ®Google Scholar
• Loberg RD, Ying C, Craig M, et al. CCL2 as an important mediator of prostate cancer growth in vivo through the regulation of macrophage infiltration. Neoplasia. 2007;9:556–562.
   PubMed Web of Science ®Google Scholar
• Lim SY, Yuzhalin AE, Gordon-Weeks AN, et al. Targeting the CCL2-CCR2 signaling axis in cancer metastasis. Oncotarget. 2016;7:28697–28710.
   PubMedGoogle Scholar
• Brana I, Calles A, LoRusso PM, et al. Carlumab, an anti-C-C chemokine ligand 2 monoclonal antibody, in combination with four chemotherapy regimens for the treatment of patients with solid tumors: an open-label, multicenter phase 1b study. Target Oncol. 2015;10:111–123.
   PubMed Web of Science ®Google Scholar
• Korner A, Pazaitou-Panayiotou K, Kelesidis T, et al. Total and high-molecular-weight adiponectin in breast cancer: in vitro and in vivo studies. J Clin Endocrinol Metab. 2007;92:1041–1048.
   PubMed Web of Science ®Google Scholar
• Gao F, Chattopadhyay A, Navab M, et al. Apolipoprotein A-I mimetic peptides inhibit expression and activity of hypoxia-inducible factor-1alpha in human ovarian cancer cell lines and a mouse ovarian cancer model. J Pharmacol Exp Ther. 2012;342:255–262.
   PubMed Web of Science ®Google Scholar
• Zhou W, Tu Y, Simpson PJ, et al. Malonyl-CoA decarboxylase inhibition is selectively cytotoxic to human breast cancer cells. Oncogene. 2009;28:2979–2987.
   PubMed Web of Science ®Google Scholar
• Pascual G, Avgustinova A, Mejetta S, et al. Targeting metastasis-initiating cells through the fatty acid receptor CD36. Nature. 2017;541:41–45.
   PubMed Web of Science ®Google Scholar